Beacon Investment Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $178K | Sell |
356
-754
| -68% | -$362K | 0.01% | 264 |
|
|
2026
Q1 | $546K | Sell |
1,110
-117
| -10% | -$63.5K | 0.02% | 175 |
|
|
2025
Q4 | $711K | Sell |
1,227
-1,296
| -51% | -$733K | 0.03% | 150 |
|
|
2025
Q3 | $1.22M | Sell |
2,523
-1,638
| -39% | -$762K | 0.05% | 123 |
|
|
2025
Q2 | $1.69M | Sell |
4,161
-20,699
| -83% | -$8.65M | 0.07% | 114 |
|
|
2025
Q1 | $12.4M | Sell |
24,860
-8,867
| -26% | -$4.8M | 0.58% | 54 |
|
|
2024
Q4 | $17.5M | Sell |
33,727
-1,756
| -5% | -$965K | 0.76% | 48 |
|
|
2024
Q3 | $21.9M | Sell |
35,483
-579
| -2% | -$343K | 0.91% | 41 |
|
|
2024
Q2 | $19.9M | Sell |
36,062
-1,552
| -4% | -$889K | 0.86% | 41 |
|
|
2024
Q1 | $21.9M | Sell |
37,614
-2,007
| -5% | -$1.13M | 0.94% | 36 |
|
|
2023
Q4 | $21M | Sell |
39,621
-11,497
| -22% | -$5.56M | 0.96% | 35 |
|
|
2023
Q3 | $25.9M | Buy |
51,118
+3,122
| +7% | +$1.66M | 1.27% | 26 |
|
|
2023
Q2 | $25M | Buy |
47,996
+18,712
| +64% | +$10.1M | 1.15% | 27 |
|
|
2023
Q1 | $16.9M | Sell |
29,284
-5,654
| -16% | -$3.19M | 0.82% | 38 |
|
|
2022
Q4 | $19.2M | Buy |
34,938
+3,880
| +12% | +$2.06M | 0.99% | 31 |
|
|
2022
Q3 | $15.8M | Buy |
31,058
+1,638
| +6% | +$917K | 0.87% | 39 |
|
|
2022
Q2 | $16M | Buy |
29,420
+4,187
| +17% | +$2.3M | 0.83% | 41 |
|
|
2022
Q1 | $14.9M | Buy |
25,233
+662
| +3% | +$380K | 0.64% | 48 |
|
|
2021
Q4 | $16.4M | Buy |
24,571
+12,157
| +98% | +$7.59M | 0.64% | 49 |
|
|
2021
Q3 | $7.09M | Buy |
12,414
+4,829
| +64% | +$2.65M | 0.29% | 78 |
|
|
2021
Q2 | $3.83M | Buy |
7,585
+377
| +5% | +$178K | 0.15% | 109 |
|
|
2021
Q1 | $3.29M | Buy |
7,208
+1,157
| +19% | +$552K | 0.14% | 114 |
|
|
2020
Q4 | $2.82M | Buy |
6,051
+771
| +15% | +$362K | 0.13% | 113 |
|
|
2020
Q3 | $2.33M | Buy |
5,280
+405
| +8% | +$167K | 0.12% | 120 |
|
|
2020
Q2 | $1.77M | Buy |
4,875
+2,500
| +105% | +$838K | 0.1% | 128 |
|
|
2020
Q1 | $674K | Buy |
2,375
+840
| +55% | +$265K | 0.05% | 149 |
|
|
2019
Q4 | $499K | Hold |
1,535
| – | – | 0.03% | 173 |
|
|
2019
Q3 | $447K | Hold |
1,535
| – | – | 0.04% | 166 |
|
|
2019
Q2 | $451K | Hold |
1,535
| – | – | 0.05% | 151 |
|
|
2019
Q1 | $420K | Sell |
1,535
-215
| -12% | -$53.5K | 0.04% | 161 |
|
|
2018
Q4 | $392K | Sell |
1,750
-328
| -16% | -$77K | 0.04% | 176 |
|
|
2018
Q3 | $507K | Sell |
2,078
-7
| -0.3% | -$1.61K | 0.05% | 160 |
|
|
2018
Q2 | $432K | Buy |
2,085
+12
| +0.6% | +$2.55K | 0.04% | 170 |
|
|
2018
Q1 | $428K | Buy |
2,073
+19
| +0.9% | +$3.99K | 0.04% | 168 |
|
|
2017
Q4 | $390K | Sell |
2,054
-177
| -8% | -$33.9K | 0.04% | 169 |
|
|
2017
Q3 | $422K | Buy |
+2,231
| New | +$404K | 0.04% | 195 |
|
Other funds holding TMO
RG
LT
ATO
QP
CF
Beacon Investment Advisory Services's TMO Position: Q2 2026 in Review
Beacon Investment Advisory Services reduced its Thermo Fisher Scientific (TMO) stake by 68% in Q2 2026, selling an estimated $362K and leaving 356 shares worth $178K. The position accounts for 0.01% of the portfolio, ranked #264.
Beacon Investment Advisory Services first reported a position in TMO in Q3 2017 and has held it in 36 quarters since. The position peaked at $25.9M in Q3 2023. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Beacon Investment Advisory Services held 356 shares of Thermo Fisher Scientific worth $178K as of Q2 2026.
- Beacon Investment Advisory Services sold 754 Thermo Fisher Scientific shares in Q2 2026, an estimated $362K.
- Thermo Fisher Scientific made up 0.01% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #264 holding.
- Beacon Investment Advisory Services first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 36 quarters since.
- Beacon Investment Advisory Services's Thermo Fisher Scientific position peaked at $25.9M in Q3 2023.
- 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.